TrialCancer communications (London, England)2026
Camrelizumab Plus Nab-paclitaxel in Patients with Previously Treated Advanced Urothelial Carcinoma: A Multicenter Phase II Study.
Haifeng Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.